PDB Short entry for 2VLR HEADER IMMUNE SYSTEM 15-JAN-08 2VLR TITLE THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL TITLE 2 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, F; COMPND 4 FRAGMENT: HLA-A2, RESIDUES 25-300; COMPND 5 SYNONYM: MHC CLASS I ANTIGEN A*2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B, G; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: FLU MATRIX PEPTIDE; COMPND 13 CHAIN: C, H; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 4; COMPND 16 MOLECULE: JM22 TCR ALPHA CHAIN; COMPND 17 CHAIN: D, I; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 5; COMPND 20 MOLECULE: JM22 TCR BETA CHAIN; COMPND 21 CHAIN: E, J; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: UNIDENTIFIED INFLUENZA VIRUS; SOURCE 16 ORGANISM_TAXID: 11309; SOURCE 17 MOL_ID: 4; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 23 MOL_ID: 5; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM-RECEPTOR- KEYWDS 2 COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE KEYWDS 3 CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, KEYWDS 4 MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T- KEYWDS 5 CELL, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ISHIZUKA,G.STEWART-JONES,A.VAN DER MERWE,J.BELL,A.MCMICHAEL,Y.JONES REVDAT 5 18-SEP-19 2VLR 1 REMARK REVDAT 4 13-JUL-11 2VLR 1 VERSN REVDAT 3 24-FEB-09 2VLR 1 VERSN REVDAT 2 26-FEB-08 2VLR 1 JRNL REVDAT 1 22-JAN-08 2VLR 0 JRNL AUTH J.ISHIZUKA,G.STEWART-JONES,A.VAN DER MERWE,J.BELL, JRNL AUTH 2 A.MCMICHAEL,Y.JONES JRNL TITL THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT JRNL TITL 2 T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN JRNL REF IMMUNITY V. 28 171 2008 JRNL REFN ISSN 1074-7613 JRNL PMID 18275829 JRNL DOI 10.1016/J.IMMUNI.2007.12.018 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 112.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 83095 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4402 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5993 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 336 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 13236 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 583 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57000 REMARK 3 B22 (A**2) : -0.85000 REMARK 3 B33 (A**2) : -1.99000 REMARK 3 B12 (A**2) : -1.28000 REMARK 3 B13 (A**2) : -0.47000 REMARK 3 B23 (A**2) : -2.84000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.364 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.270 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.205 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.774 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 13592 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 18450 ; 1.599 ; 1.932 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1638 ; 7.249 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 694 ;36.466 ;23.948 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 2206 ;18.580 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 92 ;19.464 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1932 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10604 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4263 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 8463 ; 0.290 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 525 ; 0.188 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 92 ; 0.442 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.455 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 8587 ; 0.716 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 13244 ; 1.190 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 5996 ; 1.865 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 5206 ; 2.900 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 16 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 181 REMARK 3 ORIGIN FOR THE GROUP (A): 26.2270 8.3695 2.4817 REMARK 3 T TENSOR REMARK 3 T11: -0.0115 T22: -0.0736 REMARK 3 T33: -0.0819 T12: 0.0015 REMARK 3 T13: 0.0086 T23: 0.0267 REMARK 3 L TENSOR REMARK 3 L11: 0.8329 L22: 1.7996 REMARK 3 L33: 1.0067 L12: 0.1333 REMARK 3 L13: -0.1535 L23: 0.1564 REMARK 3 S TENSOR REMARK 3 S11: 0.0525 S12: -0.0398 S13: -0.0358 REMARK 3 S21: -0.0970 S22: 0.0236 S23: -0.0677 REMARK 3 S31: 0.1331 S32: 0.0252 S33: -0.0761 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 182 A 275 REMARK 3 ORIGIN FOR THE GROUP (A): 39.7222 -23.7598 -4.9445 REMARK 3 T TENSOR REMARK 3 T11: 0.1619 T22: 0.0152 REMARK 3 T33: 0.2497 T12: 0.3176 REMARK 3 T13: -0.1575 T23: -0.2073 REMARK 3 L TENSOR REMARK 3 L11: 4.5941 L22: 7.9720 REMARK 3 L33: 6.4644 L12: -2.5794 REMARK 3 L13: -1.8166 L23: 2.0682 REMARK 3 S TENSOR REMARK 3 S11: 0.0630 S12: 0.2220 S13: -0.1712 REMARK 3 S21: -0.0833 S22: 0.4316 S23: -1.3530 REMARK 3 S31: 1.3797 S32: 1.0592 S33: -0.4946 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): 24.0594 -11.3390 -16.1251 REMARK 3 T TENSOR REMARK 3 T11: 0.0929 T22: -0.1088 REMARK 3 T33: -0.0771 T12: 0.0390 REMARK 3 T13: -0.0132 T23: -0.0194 REMARK 3 L TENSOR REMARK 3 L11: 2.2924 L22: 2.9969 REMARK 3 L33: 1.9281 L12: 0.7494 REMARK 3 L13: 0.1448 L23: -0.2801 REMARK 3 S TENSOR REMARK 3 S11: 0.1600 S12: 0.1985 S13: -0.2453 REMARK 3 S21: -0.2130 S22: 0.0034 S23: -0.1298 REMARK 3 S31: 0.3141 S32: -0.0692 S33: -0.1633 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 9 REMARK 3 ORIGIN FOR THE GROUP (A): 25.2865 16.3738 5.0794 REMARK 3 T TENSOR REMARK 3 T11: -0.0335 T22: -0.0218 REMARK 3 T33: -0.0343 T12: 0.0270 REMARK 3 T13: -0.0458 T23: -0.0027 REMARK 3 L TENSOR REMARK 3 L11: 0.5783 L22: 3.2040 REMARK 3 L33: 3.9011 L12: -0.5935 REMARK 3 L13: -0.3935 L23: 3.4744 REMARK 3 S TENSOR REMARK 3 S11: 0.1673 S12: -0.0772 S13: 0.0719 REMARK 3 S21: 0.1351 S22: -0.0393 S23: 0.0946 REMARK 3 S31: -0.0114 S32: 0.1311 S33: -0.1280 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 1 F 181 REMARK 3 ORIGIN FOR THE GROUP (A): 26.5797 62.4493 74.6635 REMARK 3 T TENSOR REMARK 3 T11: -0.0109 T22: -0.0436 REMARK 3 T33: -0.0956 T12: -0.0049 REMARK 3 T13: 0.0031 T23: 0.0182 REMARK 3 L TENSOR REMARK 3 L11: 0.6802 L22: 1.7829 REMARK 3 L33: 1.1469 L12: 0.1812 REMARK 3 L13: 0.1166 L23: 0.0584 REMARK 3 S TENSOR REMARK 3 S11: 0.0249 S12: 0.0611 S13: 0.0654 REMARK 3 S21: 0.0693 S22: 0.0021 S23: -0.0083 REMARK 3 S31: -0.1798 S32: 0.0530 S33: -0.0270 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 182 F 275 REMARK 3 ORIGIN FOR THE GROUP (A): 39.4983 96.1196 81.4455 REMARK 3 T TENSOR REMARK 3 T11: 0.5667 T22: 0.1337 REMARK 3 T33: 0.0799 T12: -0.6179 REMARK 3 T13: 0.2263 T23: -0.1061 REMARK 3 L TENSOR REMARK 3 L11: 4.8824 L22: 5.1505 REMARK 3 L33: 8.9893 L12: 1.2797 REMARK 3 L13: -1.0990 L23: 1.4421 REMARK 3 S TENSOR REMARK 3 S11: 0.3796 S12: -0.7975 S13: 0.7345 REMARK 3 S21: 0.0827 S22: 0.1313 S23: -0.5630 REMARK 3 S31: -2.2460 S32: 1.8396 S33: -0.5110 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : G 0 G 99 REMARK 3 ORIGIN FOR THE GROUP (A): 24.6645 82.3139 93.2634 REMARK 3 T TENSOR REMARK 3 T11: 0.1119 T22: -0.0844 REMARK 3 T33: -0.0741 T12: -0.0756 REMARK 3 T13: 0.0803 T23: -0.0336 REMARK 3 L TENSOR REMARK 3 L11: 2.5710 L22: 4.1225 REMARK 3 L33: 2.0220 L12: -0.4483 REMARK 3 L13: -0.2933 L23: 0.7319 REMARK 3 S TENSOR REMARK 3 S11: 0.2237 S12: -0.2511 S13: 0.3786 REMARK 3 S21: 0.0662 S22: -0.1013 S23: 0.0188 REMARK 3 S31: -0.3736 S32: 0.0191 S33: -0.1224 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 1 H 9 REMARK 3 ORIGIN FOR THE GROUP (A): 25.4574 54.4753 72.1408 REMARK 3 T TENSOR REMARK 3 T11: 0.0368 T22: -0.0106 REMARK 3 T33: -0.0701 T12: 0.0027 REMARK 3 T13: 0.0457 T23: -0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.6636 L22: 3.9449 REMARK 3 L33: 2.1980 L12: 1.3488 REMARK 3 L13: 0.8025 L23: 2.9229 REMARK 3 S TENSOR REMARK 3 S11: 0.2733 S12: 0.1792 S13: -0.1019 REMARK 3 S21: 0.2341 S22: -0.1938 S23: 0.1469 REMARK 3 S31: 0.0321 S32: 0.0450 S33: -0.0795 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 3 D 115 REMARK 3 ORIGIN FOR THE GROUP (A): 27.5547 34.7679 27.0984 REMARK 3 T TENSOR REMARK 3 T11: -0.0288 T22: -0.0090 REMARK 3 T33: -0.0427 T12: 0.0026 REMARK 3 T13: -0.0175 T23: -0.0180 REMARK 3 L TENSOR REMARK 3 L11: 0.1789 L22: 0.8008 REMARK 3 L33: 1.9424 L12: 0.0146 REMARK 3 L13: -0.0625 L23: 0.6558 REMARK 3 S TENSOR REMARK 3 S11: -0.0620 S12: -0.0805 S13: -0.0036 REMARK 3 S21: 0.0345 S22: 0.0988 S23: -0.0158 REMARK 3 S31: -0.0490 S32: 0.1090 S33: -0.0368 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 116 D 201 REMARK 3 ORIGIN FOR THE GROUP (A): 9.6305 61.6016 39.2382 REMARK 3 T TENSOR REMARK 3 T11: 0.0519 T22: -0.1045 REMARK 3 T33: -0.0881 T12: -0.0111 REMARK 3 T13: 0.0279 T23: 0.0453 REMARK 3 L TENSOR REMARK 3 L11: 3.7846 L22: 2.4773 REMARK 3 L33: 4.2412 L12: -0.1420 REMARK 3 L13: 1.5019 L23: 1.0093 REMARK 3 S TENSOR REMARK 3 S11: -0.0760 S12: -0.3510 S13: 0.0918 REMARK 3 S21: 0.3348 S22: -0.1094 S23: 0.2296 REMARK 3 S31: 0.0016 S32: -0.5403 S33: 0.1854 REMARK 3 REMARK 3 TLS GROUP : 11 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 5 E 115 REMARK 3 ORIGIN FOR THE GROUP (A): 11.4272 34.2045 9.0861 REMARK 3 T TENSOR REMARK 3 T11: -0.0509 T22: -0.0097 REMARK 3 T33: -0.0514 T12: -0.0057 REMARK 3 T13: 0.0051 T23: 0.0219 REMARK 3 L TENSOR REMARK 3 L11: 2.0893 L22: 1.3231 REMARK 3 L33: 0.8750 L12: -0.8058 REMARK 3 L13: -0.2414 L23: 0.8047 REMARK 3 S TENSOR REMARK 3 S11: 0.0369 S12: 0.0326 S13: 0.0379 REMARK 3 S21: -0.0498 S22: -0.0674 S23: 0.0494 REMARK 3 S31: -0.0394 S32: -0.0786 S33: 0.0306 REMARK 3 REMARK 3 TLS GROUP : 12 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 116 E 244 REMARK 3 ORIGIN FOR THE GROUP (A): 7.3119 63.1701 21.9288 REMARK 3 T TENSOR REMARK 3 T11: 0.0212 T22: -0.1132 REMARK 3 T33: -0.0076 T12: 0.0058 REMARK 3 T13: -0.0359 T23: 0.0773 REMARK 3 L TENSOR REMARK 3 L11: 1.5537 L22: 2.5448 REMARK 3 L33: 1.4435 L12: 1.3526 REMARK 3 L13: 0.9308 L23: 1.0744 REMARK 3 S TENSOR REMARK 3 S11: -0.0809 S12: 0.1451 S13: 0.1962 REMARK 3 S21: 0.0476 S22: -0.0873 S23: 0.1687 REMARK 3 S31: -0.2499 S32: -0.0318 S33: 0.1682 REMARK 3 REMARK 3 TLS GROUP : 13 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 3 I 115 REMARK 3 ORIGIN FOR THE GROUP (A): 27.5203 35.5745 50.5099 REMARK 3 T TENSOR REMARK 3 T11: -0.0353 T22: -0.0188 REMARK 3 T33: -0.0306 T12: 0.0097 REMARK 3 T13: 0.0314 T23: -0.0213 REMARK 3 L TENSOR REMARK 3 L11: 0.4189 L22: 0.9965 REMARK 3 L33: 1.9894 L12: -0.1851 REMARK 3 L13: -0.4638 L23: 0.2209 REMARK 3 S TENSOR REMARK 3 S11: -0.0634 S12: 0.0304 S13: -0.0617 REMARK 3 S21: -0.0969 S22: 0.0434 S23: -0.0204 REMARK 3 S31: 0.1022 S32: 0.0145 S33: 0.0200 REMARK 3 REMARK 3 TLS GROUP : 14 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 116 I 201 REMARK 3 ORIGIN FOR THE GROUP (A): 9.6780 7.9373 39.5020 REMARK 3 T TENSOR REMARK 3 T11: 0.0484 T22: -0.1021 REMARK 3 T33: -0.1075 T12: -0.2722 REMARK 3 T13: 0.2358 T23: -0.3035 REMARK 3 L TENSOR REMARK 3 L11: 7.0537 L22: 5.5725 REMARK 3 L33: 9.0097 L12: 1.6065 REMARK 3 L13: -1.3433 L23: 2.4968 REMARK 3 S TENSOR REMARK 3 S11: -0.2807 S12: 0.5811 S13: -0.7298 REMARK 3 S21: -1.2547 S22: 0.2496 S23: -0.4799 REMARK 3 S31: -0.0707 S32: -0.4905 S33: 0.0311 REMARK 3 REMARK 3 TLS GROUP : 15 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : J 5 J 115 REMARK 3 ORIGIN FOR THE GROUP (A): 11.1345 36.6364 68.4211 REMARK 3 T TENSOR REMARK 3 T11: -0.0694 T22: 0.0471 REMARK 3 T33: -0.0621 T12: 0.0131 REMARK 3 T13: 0.0098 T23: 0.0082 REMARK 3 L TENSOR REMARK 3 L11: 1.9557 L22: 1.5118 REMARK 3 L33: 0.7888 L12: 1.0837 REMARK 3 L13: 0.4144 L23: 0.6630 REMARK 3 S TENSOR REMARK 3 S11: 0.0637 S12: -0.1668 S13: 0.0153 REMARK 3 S21: 0.0393 S22: -0.1233 S23: 0.0860 REMARK 3 S31: 0.0560 S32: -0.1508 S33: 0.0596 REMARK 3 REMARK 3 TLS GROUP : 16 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : J 116 J 244 REMARK 3 ORIGIN FOR THE GROUP (A): 6.4762 7.2691 56.9435 REMARK 3 T TENSOR REMARK 3 T11: -0.1208 T22: -0.1798 REMARK 3 T33: 0.1272 T12: -0.0667 REMARK 3 T13: 0.0513 T23: 0.0195 REMARK 3 L TENSOR REMARK 3 L11: 3.7488 L22: 4.8209 REMARK 3 L33: 3.1129 L12: -0.8620 REMARK 3 L13: -1.4665 L23: 2.5106 REMARK 3 S TENSOR REMARK 3 S11: -0.1353 S12: -0.0244 S13: -0.7990 REMARK 3 S21: -0.1802 S22: 0.0989 S23: -0.2454 REMARK 3 S31: 0.1223 S32: -0.0562 S33: 0.0364 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VLR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1290035032. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1032287 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 11.80 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 11730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -72.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, G, H, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET D 2 REMARK 465 LYS D 202 REMARK 465 MET E 1 REMARK 465 VAL E 2 REMARK 465 ASP E 3 REMARK 465 GLY E 4 REMARK 465 MET I 2 REMARK 465 LYS I 202 REMARK 465 MET J 1 REMARK 465 VAL J 2 REMARK 465 ASP J 3 REMARK 465 GLY J 4 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 224 CB REMARK 480 GLN F 224 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB ASP F 223 CB GLN F 224 1.64 REMARK 500 NH1 ARG A 17 O HOH A 2007 1.91 REMARK 500 O THR E 81 N ALA E 83 1.96 REMARK 500 OD1 ASN E 86 O HOH E 2054 2.07 REMARK 500 NH1 ARG D 61 OD2 ASP D 84 2.07 REMARK 500 O GLN J 84 N ASN J 86 2.07 REMARK 500 NH2 ARG A 17 O HOH A 2007 2.08 REMARK 500 O HOH G 2001 O HOH G 2011 2.16 REMARK 500 O ALA F 184 O HOH F 2052 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 SD MET A 138 OE2 GLU G 36 1544 1.67 REMARK 500 NH2 ARG B 81 SD MET F 138 1444 2.05 REMARK 500 CZ ARG B 81 SD MET F 138 1444 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 224 CA GLN A 224 CB 2.603 REMARK 500 GLN A 224 CB GLN A 224 CG -1.066 REMARK 500 CYS B 25 CB CYS B 25 SG 0.103 REMARK 500 GLN F 224 CA GLN F 224 CB 4.079 REMARK 500 GLN F 224 CB GLN F 224 CG 1.243 REMARK 500 GLN F 224 CD GLN F 224 OE1 0.284 REMARK 500 LYS I 158 CE LYS I 158 NZ 0.329 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 44 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 GLN A 224 CB - CA - C ANGL. DEV. = -24.5 DEGREES REMARK 500 GLN A 224 N - CA - CB ANGL. DEV. = -37.5 DEGREES REMARK 500 GLN A 224 CA - CB - CG ANGL. DEV. = -94.9 DEGREES REMARK 500 LEU D 75 CA - CB - CG ANGL. DEV. = 17.9 DEGREES REMARK 500 LEU D 161 CA - CB - CG ANGL. DEV. = 22.1 DEGREES REMARK 500 ASP E 40 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 GLY F 18 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 GLN F 224 CB - CA - C ANGL. DEV. = -26.0 DEGREES REMARK 500 GLN F 224 N - CA - CB ANGL. DEV. = -82.5 DEGREES REMARK 500 GLN F 224 CA - CB - CG ANGL. DEV. = 23.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 17 -58.00 78.85 REMARK 500 ASP A 29 -118.47 52.68 REMARK 500 LEU A 110 -50.53 -123.88 REMARK 500 HIS A 114 101.13 -169.54 REMARK 500 THR A 178 -40.05 -134.31 REMARK 500 SER A 195 -149.66 -136.06 REMARK 500 ASP A 220 -66.05 57.01 REMARK 500 GLU A 222 -145.29 -132.86 REMARK 500 ASP A 227 26.58 43.07 REMARK 500 GLU A 254 37.13 -77.39 REMARK 500 GLN A 255 -5.50 -145.70 REMARK 500 SER B 20 151.71 -48.10 REMARK 500 ASN B 21 -174.40 -173.10 REMARK 500 PRO B 32 -175.36 -62.30 REMARK 500 TRP B 60 -21.69 88.38 REMARK 500 VAL D 51 -40.62 -135.36 REMARK 500 LYS D 60 -123.82 50.13 REMARK 500 ASP D 117 56.56 -141.81 REMARK 500 LYS D 127 54.53 -107.03 REMARK 500 ASP D 130 -154.95 70.71 REMARK 500 LYS D 131 120.08 57.49 REMARK 500 LYS D 179 139.49 -33.91 REMARK 500 PRO D 200 126.82 -30.34 REMARK 500 ASN E 30 34.80 70.38 REMARK 500 ILE E 53 145.18 -172.43 REMARK 500 ARG E 70 68.75 -151.08 REMARK 500 SER E 82 62.23 -52.91 REMARK 500 ALA E 83 -118.28 -55.01 REMARK 500 ASN E 86 34.92 -147.22 REMARK 500 SER E 100 -12.93 85.33 REMARK 500 ASP E 185 49.97 -105.55 REMARK 500 ASP F 29 -118.63 55.56 REMARK 500 HIS F 114 97.43 -166.74 REMARK 500 ASP F 122 128.81 -35.16 REMARK 500 HIS F 197 7.99 -158.76 REMARK 500 ARG F 219 102.64 -169.81 REMARK 500 ASP F 220 -75.89 55.28 REMARK 500 GLU F 222 -92.03 -172.76 REMARK 500 ASP F 223 -82.29 -162.76 REMARK 500 GLN F 224 -129.20 106.63 REMARK 500 THR F 225 41.77 -146.47 REMARK 500 GLN F 226 -114.60 -73.43 REMARK 500 VAL F 248 71.15 -114.92 REMARK 500 GLN F 253 36.87 -145.87 REMARK 500 ASN G 21 -169.25 -162.38 REMARK 500 TRP G 60 -8.25 76.98 REMARK 500 ARG G 97 -44.35 -29.16 REMARK 500 GLU I 16 129.49 -38.13 REMARK 500 LYS I 60 -118.08 41.09 REMARK 500 ASP I 117 55.20 -148.27 REMARK 500 REMARK 500 THIS ENTRY HAS 70 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG F 17 GLY F 18 128.02 REMARK 500 GLN J 84 LYS J 85 -138.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1N2R RELATED DB: PDB REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF,PEPTIDE REMARK 900 REPORTOIRE AND T CELL RECOGNITION. REMARK 900 RELATED ID: 2VLK RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA- A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 2BSU RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 2J8U RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE ( RESIDUES 412-420) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2BSV RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 2VLL RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2VLJ RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 900 RELATED ID: 2VLM RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN DBREF 2VLR A 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2VLR B 0 0 PDB 2VLR 2VLR 0 0 DBREF 2VLR B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2VLR C 1 9 PDB 2VLR 2VLR 1 9 DBREF 2VLR D 2 202 PDB 2VLR 2VLR 2 202 DBREF 2VLR E 1 244 PDB 2VLR 2VLR 1 244 DBREF 2VLR F 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2VLR G 0 0 PDB 2VLR 2VLR 0 0 DBREF 2VLR G 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2VLR H 1 9 PDB 2VLR 2VLR 1 9 DBREF 2VLR I 2 202 PDB 2VLR 2VLR 2 202 DBREF 2VLR J 1 244 PDB 2VLR 2VLR 1 244 SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 GLY ILE LEU GLY PHE VAL PHE THR LEU SEQRES 1 D 201 MET GLN LEU LEU GLU GLN SER PRO GLN PHE LEU SER ILE SEQRES 2 D 201 GLN GLU GLY GLU ASN LEU THR VAL TYR CYS ASN SER SER SEQRES 3 D 201 SER VAL PHE SER SER LEU GLN TRP TYR ARG GLN GLU PRO SEQRES 4 D 201 GLY GLU GLY PRO VAL LEU LEU VAL THR VAL VAL THR GLY SEQRES 5 D 201 GLY GLU VAL LYS LYS LEU LYS ARG LEU THR PHE GLN PHE SEQRES 6 D 201 GLY ASP ALA ARG LYS ASP SER SER LEU HIS ILE THR ALA SEQRES 7 D 201 ALA GLN PRO GLY ASP THR GLY LEU TYR LEU CYS ALA GLY SEQRES 8 D 201 ALA GLY SER GLN GLY ASN LEU ILE PHE GLY LYS GLY THR SEQRES 9 D 201 LYS LEU SER VAL LYS PRO ASN ILE GLN ASN PRO ASP PRO SEQRES 10 D 201 ALA VAL TYR GLN LEU ARG ASP SER LYS SER SER ASP LYS SEQRES 11 D 201 SER VAL CYS LEU PHE THR ASP PHE ASP SER GLN THR ASN SEQRES 12 D 201 VAL SER GLN SER LYS ASP SER ASP VAL TYR ILE THR ASP SEQRES 13 D 201 LYS THR VAL LEU ASP MET ARG SER MET ASP PHE LYS SER SEQRES 14 D 201 ASN SER ALA VAL ALA TRP SER ASN LYS SER ASP PHE ALA SEQRES 15 D 201 CYS ALA ASN ALA PHE ASN ASN SER ILE ILE PRO GLU ASP SEQRES 16 D 201 THR PHE PHE PRO SER LYS SEQRES 1 E 244 MET VAL ASP GLY GLY ILE THR GLN SER PRO LYS TYR LEU SEQRES 2 E 244 PHE ARG LYS GLU GLY GLN ASN VAL THR LEU SER CYS GLU SEQRES 3 E 244 GLN ASN LEU ASN HIS ASP ALA MET TYR TRP TYR ARG GLN SEQRES 4 E 244 ASP PRO GLY GLN GLY LEU ARG LEU ILE TYR TYR SER GLN SEQRES 5 E 244 ILE VAL ASN ASP PHE GLN LYS GLY ASP ILE ALA GLU GLY SEQRES 6 E 244 TYR SER VAL SER ARG GLU LYS LYS GLU SER PHE PRO LEU SEQRES 7 E 244 THR VAL THR SER ALA GLN LYS ASN PRO THR ALA PHE TYR SEQRES 8 E 244 LEU CYS ALA SER SER SER ARG ALA SER TYR GLU GLN TYR SEQRES 9 E 244 PHE GLY PRO GLY THR ARG LEU THR VAL THR GLU ASP LEU SEQRES 10 E 244 LYS ASN VAL PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SEQRES 11 E 244 SER GLU ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU SEQRES 12 E 244 VAL CYS LEU ALA THR GLY PHE TYR PRO ASP HIS VAL GLU SEQRES 13 E 244 LEU SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY SEQRES 14 E 244 VAL SER THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA SEQRES 15 E 244 LEU ASN ASP SER ARG TYR SER LEU SER SER ARG LEU ARG SEQRES 16 E 244 VAL SER ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE SEQRES 17 E 244 ARG CYS GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP SEQRES 18 E 244 GLU TRP THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE SEQRES 19 E 244 VAL SER ALA GLU ALA TRP GLY ARG ALA ASP SEQRES 1 F 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 F 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 F 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 F 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 F 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 F 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 F 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 F 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 F 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 F 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 F 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 F 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 F 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 F 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 F 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 F 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 F 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 F 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 F 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 F 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 F 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 F 276 TRP GLU PRO SEQRES 1 G 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 G 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 G 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 G 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 G 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 G 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 G 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 G 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 H 9 GLY ILE LEU GLY PHE VAL PHE THR LEU SEQRES 1 I 201 MET GLN LEU LEU GLU GLN SER PRO GLN PHE LEU SER ILE SEQRES 2 I 201 GLN GLU GLY GLU ASN LEU THR VAL TYR CYS ASN SER SER SEQRES 3 I 201 SER VAL PHE SER SER LEU GLN TRP TYR ARG GLN GLU PRO SEQRES 4 I 201 GLY GLU GLY PRO VAL LEU LEU VAL THR VAL VAL THR GLY SEQRES 5 I 201 GLY GLU VAL LYS LYS LEU LYS ARG LEU THR PHE GLN PHE SEQRES 6 I 201 GLY ASP ALA ARG LYS ASP SER SER LEU HIS ILE THR ALA SEQRES 7 I 201 ALA GLN PRO GLY ASP THR GLY LEU TYR LEU CYS ALA GLY SEQRES 8 I 201 ALA GLY SER GLN GLY ASN LEU ILE PHE GLY LYS GLY THR SEQRES 9 I 201 LYS LEU SER VAL LYS PRO ASN ILE GLN ASN PRO ASP PRO SEQRES 10 I 201 ALA VAL TYR GLN LEU ARG ASP SER LYS SER SER ASP LYS SEQRES 11 I 201 SER VAL CYS LEU PHE THR ASP PHE ASP SER GLN THR ASN SEQRES 12 I 201 VAL SER GLN SER LYS ASP SER ASP VAL TYR ILE THR ASP SEQRES 13 I 201 LYS THR VAL LEU ASP MET ARG SER MET ASP PHE LYS SER SEQRES 14 I 201 ASN SER ALA VAL ALA TRP SER ASN LYS SER ASP PHE ALA SEQRES 15 I 201 CYS ALA ASN ALA PHE ASN ASN SER ILE ILE PRO GLU ASP SEQRES 16 I 201 THR PHE PHE PRO SER LYS SEQRES 1 J 244 MET VAL ASP GLY GLY ILE THR GLN SER PRO LYS TYR LEU SEQRES 2 J 244 PHE ARG LYS GLU GLY GLN ASN VAL THR LEU SER CYS GLU SEQRES 3 J 244 GLN ASN LEU ASN HIS ASP ALA MET TYR TRP TYR ARG GLN SEQRES 4 J 244 ASP PRO GLY GLN GLY LEU ARG LEU ILE TYR TYR SER GLN SEQRES 5 J 244 ILE VAL ASN ASP PHE GLN LYS GLY ASP ILE ALA GLU GLY SEQRES 6 J 244 TYR SER VAL SER ARG GLU LYS LYS GLU SER PHE PRO LEU SEQRES 7 J 244 THR VAL THR SER ALA GLN LYS ASN PRO THR ALA PHE TYR SEQRES 8 J 244 LEU CYS ALA SER SER SER ARG ALA SER TYR GLU GLN TYR SEQRES 9 J 244 PHE GLY PRO GLY THR ARG LEU THR VAL THR GLU ASP LEU SEQRES 10 J 244 LYS ASN VAL PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SEQRES 11 J 244 SER GLU ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU SEQRES 12 J 244 VAL CYS LEU ALA THR GLY PHE TYR PRO ASP HIS VAL GLU SEQRES 13 J 244 LEU SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY SEQRES 14 J 244 VAL SER THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA SEQRES 15 J 244 LEU ASN ASP SER ARG TYR SER LEU SER SER ARG LEU ARG SEQRES 16 J 244 VAL SER ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE SEQRES 17 J 244 ARG CYS GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP SEQRES 18 J 244 GLU TRP THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE SEQRES 19 J 244 VAL SER ALA GLU ALA TRP GLY ARG ALA ASP FORMUL 11 HOH *583(H2 O) HELIX 1 1 TRP A 51 GLU A 55 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLN D 81 THR D 85 5 5 HELIX 8 8 ALA D 183 PHE D 188 1 6 HELIX 9 9 ASP E 116 VAL E 120 5 5 HELIX 10 10 SER E 131 GLN E 139 1 9 HELIX 11 11 ALA E 198 GLN E 202 1 5 HELIX 12 12 ALA F 49 GLU F 55 5 7 HELIX 13 13 GLY F 56 TYR F 85 1 30 HELIX 14 14 ASP F 137 ALA F 150 1 14 HELIX 15 15 HIS F 151 GLY F 162 1 12 HELIX 16 16 GLY F 162 GLY F 175 1 14 HELIX 17 17 GLY F 175 GLN F 180 1 6 HELIX 18 18 GLN F 253 TYR F 257 5 5 HELIX 19 19 GLN I 81 THR I 85 5 5 HELIX 20 20 ARG I 164 ASP I 167 5 4 HELIX 21 21 ASP J 116 VAL J 120 5 5 HELIX 22 22 SER J 131 GLN J 139 1 9 HELIX 23 23 ALA J 198 GLN J 202 1 5 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 GLU A 229 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AD 3 THR A 214 ARG A 219 0 SHEET 2 AD 3 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 3 AD 3 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 5 GLU D 6 SER D 8 0 SHEET 2 DA 5 LEU D 20 ASN D 25 -1 O TYR D 23 N SER D 8 SHEET 3 DA 5 ASP D 72 ILE D 77 -1 O SER D 73 N CYS D 24 SHEET 4 DA 5 LEU D 62 PHE D 66 -1 O THR D 63 N HIS D 76 SHEET 5 DA 5 VAL D 56 LEU D 59 -1 O LYS D 57 N PHE D 64 SHEET 1 DB 5 PHE D 11 GLN D 15 0 SHEET 2 DB 5 THR D 105 LYS D 110 1 O LYS D 106 N LEU D 12 SHEET 3 DB 5 GLY D 86 ALA D 93 -1 O GLY D 86 N LEU D 107 SHEET 4 DB 5 LEU D 33 GLN D 38 -1 O GLN D 34 N ALA D 91 SHEET 5 DB 5 VAL D 45 VAL D 50 -1 O VAL D 45 N ARG D 37 SHEET 1 DC 4 PHE D 11 GLN D 15 0 SHEET 2 DC 4 THR D 105 LYS D 110 1 O LYS D 106 N LEU D 12 SHEET 3 DC 4 GLY D 86 ALA D 93 -1 O GLY D 86 N LEU D 107 SHEET 4 DC 4 LEU D 99 PHE D 101 -1 O ILE D 100 N GLY D 92 SHEET 1 DD 7 ALA D 119 ARG D 124 0 SHEET 2 DD 7 SER D 132 THR D 137 -1 O VAL D 133 N LEU D 123 SHEET 3 DD 7 PHE D 168 SER D 177 -1 O ALA D 173 N PHE D 136 SHEET 4 DD 7 VAL D 153 ILE D 155 -1 O TYR D 154 N TRP D 176 SHEET 5 DD 7 PHE D 168 SER D 177 -1 O TRP D 176 N TYR D 154 SHEET 6 DD 7 THR D 159 MET D 163 -1 O THR D 159 N SER D 172 SHEET 7 DD 7 PHE D 168 SER D 177 -1 O PHE D 168 N MET D 163 SHEET 1 EA 2 ILE E 6 THR E 7 0 SHEET 2 EA 2 GLU E 26 GLN E 27 -1 O GLU E 26 N THR E 7 SHEET 1 EB 9 TYR E 12 LYS E 16 0 SHEET 2 EB 9 THR E 109 THR E 114 1 O ARG E 110 N LEU E 13 SHEET 3 EB 9 ALA E 89 SER E 96 -1 O ALA E 89 N LEU E 111 SHEET 4 EB 9 ASP E 56 LYS E 59 0 SHEET 5 EB 9 LEU E 45 ILE E 53 -1 O TYR E 50 N GLN E 58 SHEET 6 EB 9 ALA E 33 GLN E 39 -1 O MET E 34 N SER E 51 SHEET 7 EB 9 ALA E 89 SER E 96 -1 O PHE E 90 N GLN E 39 SHEET 8 EB 9 TYR E 104 PHE E 105 -1 O TYR E 104 N SER E 95 SHEET 9 EB 9 ALA E 89 SER E 96 -1 O SER E 95 N TYR E 104 SHEET 1 EC 3 VAL E 21 LEU E 23 0 SHEET 2 EC 3 LEU E 78 VAL E 80 -1 O LEU E 78 N LEU E 23 SHEET 3 EC 3 TYR E 66 VAL E 68 -1 O SER E 67 N THR E 79 SHEET 1 ED 7 GLU E 124 PHE E 128 0 SHEET 2 ED 7 LYS E 140 PHE E 150 -1 O VAL E 144 N PHE E 128 SHEET 3 ED 7 TYR E 188 SER E 197 -1 O TYR E 188 N PHE E 150 SHEET 4 ED 7 VAL E 170 THR E 172 -1 O SER E 171 N ARG E 193 SHEET 5 ED 7 TYR E 188 SER E 197 -1 O ARG E 193 N SER E 171 SHEET 6 ED 7 LEU E 177 LYS E 178 -1 O LEU E 177 N SER E 189 SHEET 7 ED 7 TYR E 188 SER E 197 -1 O SER E 189 N LEU E 177 SHEET 1 EE 4 LYS E 164 VAL E 166 0 SHEET 2 EE 4 VAL E 155 VAL E 161 -1 O TRP E 159 N VAL E 166 SHEET 3 EE 4 HIS E 207 PHE E 214 -1 O ARG E 209 N TRP E 160 SHEET 4 EE 4 GLN E 233 TRP E 240 -1 O GLN E 233 N PHE E 214 SHEET 1 FA 8 GLU F 46 PRO F 47 0 SHEET 2 FA 8 THR F 31 ASP F 37 -1 O ARG F 35 N GLU F 46 SHEET 3 FA 8 ARG F 21 VAL F 28 -1 O ALA F 24 N PHE F 36 SHEET 4 FA 8 HIS F 3 VAL F 12 -1 O ARG F 6 N TYR F 27 SHEET 5 FA 8 THR F 94 VAL F 103 -1 O VAL F 95 N SER F 11 SHEET 6 FA 8 PHE F 109 TYR F 118 -1 N LEU F 110 O ASP F 102 SHEET 7 FA 8 LYS F 121 LEU F 126 -1 O LYS F 121 N TYR F 118 SHEET 8 FA 8 TRP F 133 ALA F 135 -1 O THR F 134 N ALA F 125 SHEET 1 FB 4 HIS F 191 ALA F 193 0 SHEET 2 FB 4 ALA F 199 PHE F 208 -1 O THR F 200 N HIS F 192 SHEET 3 FB 4 PHE F 241 VAL F 247 -1 O PHE F 241 N PHE F 208 SHEET 4 FB 4 ARG F 234 PRO F 235 -1 O ARG F 234 N GLN F 242 SHEET 1 FC 3 THR F 214 GLN F 218 0 SHEET 2 FC 3 THR F 258 GLN F 262 -1 O THR F 258 N GLN F 218 SHEET 3 FC 3 LEU F 270 LEU F 272 -1 O LEU F 270 N VAL F 261 SHEET 1 GA 7 LYS G 6 SER G 11 0 SHEET 2 GA 7 ASN G 21 PHE G 30 -1 O ASN G 24 N TYR G 10 SHEET 3 GA 7 PHE G 62 PHE G 70 -1 O PHE G 62 N PHE G 30 SHEET 4 GA 7 GLU G 50 HIS G 51 -1 O GLU G 50 N TYR G 67 SHEET 5 GA 7 PHE G 62 PHE G 70 -1 O TYR G 67 N GLU G 50 SHEET 6 GA 7 SER G 55 PHE G 56 -1 O SER G 55 N TYR G 63 SHEET 7 GA 7 PHE G 62 PHE G 70 -1 O TYR G 63 N SER G 55 SHEET 1 GB 4 GLU G 44 ARG G 45 0 SHEET 2 GB 4 GLU G 36 LYS G 41 -1 O LYS G 41 N GLU G 44 SHEET 3 GB 4 TYR G 78 ASN G 83 -1 O ALA G 79 N LEU G 40 SHEET 4 GB 4 LYS G 91 LYS G 94 -1 O LYS G 91 N VAL G 82 SHEET 1 IA 5 GLU I 6 SER I 8 0 SHEET 2 IA 5 LEU I 20 ASN I 25 -1 O TYR I 23 N SER I 8 SHEET 3 IA 5 ASP I 72 ILE I 77 -1 O SER I 73 N CYS I 24 SHEET 4 IA 5 LEU I 62 PHE I 66 -1 O THR I 63 N HIS I 76 SHEET 5 IA 5 VAL I 56 LEU I 59 -1 O LYS I 57 N PHE I 64 SHEET 1 IB 8 PHE I 11 GLN I 15 0 SHEET 2 IB 8 THR I 105 LYS I 110 1 O LYS I 106 N LEU I 12 SHEET 3 IB 8 GLY I 86 ALA I 93 -1 O GLY I 86 N LEU I 107 SHEET 4 IB 8 VAL I 45 VAL I 50 0 SHEET 5 IB 8 LEU I 33 GLN I 38 -1 O LEU I 33 N VAL I 50 SHEET 6 IB 8 GLY I 86 ALA I 93 -1 O LEU I 87 N GLN I 38 SHEET 7 IB 8 LEU I 99 PHE I 101 -1 O ILE I 100 N GLY I 92 SHEET 8 IB 8 GLY I 86 ALA I 93 -1 O GLY I 92 N ILE I 100 SHEET 1 IC 7 ALA I 119 GLN I 122 0 SHEET 2 IC 7 VAL I 133 THR I 137 -1 O LEU I 135 N TYR I 121 SHEET 3 IC 7 LYS I 169 SER I 177 -1 O ALA I 173 N PHE I 136 SHEET 4 IC 7 VAL I 153 ILE I 155 -1 O TYR I 154 N TRP I 176 SHEET 5 IC 7 LYS I 169 SER I 177 -1 O TRP I 176 N TYR I 154 SHEET 6 IC 7 THR I 159 ASP I 162 -1 O THR I 159 N SER I 172 SHEET 7 IC 7 LYS I 169 SER I 177 -1 O SER I 170 N LEU I 161 SHEET 1 ID 8 ARG I 124 ASP I 125 0 SHEET 2 ID 8 GLU J 124 GLU J 129 -1 O GLU J 129 N ARG I 124 SHEET 3 ID 8 LYS J 140 PHE J 150 -1 O VAL J 144 N PHE J 128 SHEET 4 ID 8 TYR J 188 SER J 197 -1 O TYR J 188 N PHE J 150 SHEET 5 ID 8 VAL J 170 THR J 172 -1 O SER J 171 N ARG J 193 SHEET 6 ID 8 TYR J 188 SER J 197 -1 O ARG J 193 N SER J 171 SHEET 7 ID 8 LEU J 177 LYS J 178 -1 O LEU J 177 N SER J 189 SHEET 8 ID 8 TYR J 188 SER J 197 -1 O SER J 189 N LEU J 177 SHEET 1 JA 2 ILE J 6 THR J 7 0 SHEET 2 JA 2 GLU J 26 GLN J 27 -1 O GLU J 26 N THR J 7 SHEET 1 JB 9 TYR J 12 LYS J 16 0 SHEET 2 JB 9 THR J 109 THR J 114 1 O ARG J 110 N LEU J 13 SHEET 3 JB 9 ALA J 89 SER J 96 -1 O ALA J 89 N LEU J 111 SHEET 4 JB 9 ASP J 56 LYS J 59 0 SHEET 5 JB 9 ARG J 46 ILE J 53 -1 O TYR J 50 N GLN J 58 SHEET 6 JB 9 ALA J 33 GLN J 39 -1 O MET J 34 N SER J 51 SHEET 7 JB 9 ALA J 89 SER J 96 -1 O PHE J 90 N GLN J 39 SHEET 8 JB 9 TYR J 104 PHE J 105 -1 O TYR J 104 N SER J 95 SHEET 9 JB 9 ALA J 89 SER J 96 -1 O SER J 95 N TYR J 104 SHEET 1 JC 3 VAL J 21 LEU J 23 0 SHEET 2 JC 3 LEU J 78 VAL J 80 -1 O LEU J 78 N LEU J 23 SHEET 3 JC 3 TYR J 66 VAL J 68 -1 O SER J 67 N THR J 79 SHEET 1 JD 4 GLU J 165 VAL J 166 0 SHEET 2 JD 4 VAL J 155 VAL J 161 -1 O TRP J 159 N VAL J 166 SHEET 3 JD 4 HIS J 207 PHE J 214 -1 O ARG J 209 N TRP J 160 SHEET 4 JD 4 GLN J 233 TRP J 240 -1 O GLN J 233 N PHE J 214 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.13 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.07 SSBOND 4 CYS D 24 CYS D 90 1555 1555 2.05 SSBOND 5 CYS D 134 CYS D 184 1555 1555 2.05 SSBOND 6 CYS E 25 CYS E 93 1555 1555 1.99 SSBOND 7 CYS E 145 CYS E 210 1555 1555 2.04 SSBOND 8 CYS F 101 CYS F 164 1555 1555 2.11 SSBOND 9 CYS F 203 CYS F 259 1555 1555 2.03 SSBOND 10 CYS G 25 CYS G 80 1555 1555 2.07 SSBOND 11 CYS I 24 CYS I 90 1555 1555 2.08 SSBOND 12 CYS I 134 CYS I 184 1555 1555 2.05 SSBOND 13 CYS J 25 CYS J 93 1555 1555 2.04 SSBOND 14 CYS J 145 CYS J 210 1555 1555 2.04 CISPEP 1 GLY A 16 ARG A 17 0 24.43 CISPEP 2 TYR A 209 PRO A 210 0 3.94 CISPEP 3 HIS B 31 PRO B 32 0 -0.45 CISPEP 4 SER D 8 PRO D 9 0 -3.12 CISPEP 5 SER E 9 PRO E 10 0 -6.92 CISPEP 6 TYR E 151 PRO E 152 0 1.74 CISPEP 7 TYR F 209 PRO F 210 0 0.33 CISPEP 8 HIS G 31 PRO G 32 0 -1.05 CISPEP 9 SER I 8 PRO I 9 0 -0.73 CISPEP 10 SER J 9 PRO J 10 0 -12.55 CISPEP 11 TYR J 151 PRO J 152 0 -0.26 CRYST1 48.622 95.523 122.045 110.29 98.64 93.59 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020567 0.001290 0.003851 0.00000 SCALE2 0.000000 0.010489 0.004060 0.00000 SCALE3 0.000000 0.000000 0.008887 0.00000